Results 121 to 130 of about 87,239 (208)

Survival prediction in stage II/III rectal cancer: Role of immune-inflammatory biomarkers post neoadjuvant chemoradiotherapy. [PDF]

Oncol Lett
Li B, Huang T, Xu S, Ye Y, Liu Y, Wang X, Wang Y.   +6 more
europepmc   +1 more source

Comment on: "Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy." [PDF]

Clin Transl Radiat Oncol
Lamba P.
europepmc   +1 more source

Glioblastoma cells that evade chemoradiotherapy-induced cell death exhibit a bifurcated glycolytic program. [PDF]

Cell Death Dis
Martell E, Kuzmychova H, Chawla U, Grewal A, Jain C, Venugopal C, Anderson CM, Singh SK, Sharif T.   +8 more
europepmc   +1 more source

Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma. [PDF]

Cancer Rep (Hoboken)
Wang Z, He Q, Jiang D, Cheng S, Gao J, Wang Y, Fu S, Cui QY, Yang Y, Lv L, Xu Y, Li Y, Tian R, Ge C, Li R.   +14 more
europepmc   +1 more source

Oropharyngeal cancer management in the era of artificial intelligence for optimal decision-making. [PDF]

Braz J Otorhinolaryngol
Castro MAF, Dedivitis RA, Matos LL, Trindade CP, Duarte BPF, Kowalski LP.   +5 more
europepmc   +1 more source

Managing Rectal Adenocarcinoma in a Radiation-Exposed Patient: A Case Report Utilizing the PROSPECT Trial Protocol. [PDF]

Cureus
Al-Assil T, Han J, Kim E, Seneriches J, Hasan N.   +4 more
europepmc   +1 more source

Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment. [PDF]

Cancers (Basel)
Taniyama Y, Jingu K, Sato C, Okamoto H, Ozawa Y, Ishida H, Ujiie N, Unno M, Kamei T.   +8 more
europepmc   +1 more source

Prior curative-intent treatment strategy affects progression outcomes of first-line immunotherapy in metastatic non-small cell lung cancer: A retrospective cohort study. [PDF]

Exp Ther Med
Cekin R, Senocak D, Arici S, Ozgun A.
europepmc   +1 more source